Related Funds
Funds with similar focus
Fund Name | Location |
ABK Technologies, LLC | Dallas, Texas, United States |
Activa Capital | France, Ile-de-France, Paris |
AEON Financial | Chiyoda, Japan |
Bulldozer | Canada, Quebec, Quebec |
Feik Enterprises | - |
Guizhang Venture Capital | - |
Lowe's Innovation Labs | Bengaluru, India, Karnataka |
Lumiere Capital | China, Shanghai |
Parity Responsible Technology Fund | - |
QBE Ventures | Australia, New South Wales, Sydney |
QianKunHanHai | - |
Scudder Technology Fund | Chicago, Illinois, United States |
Shadow Foundr | England, London, United Kingdom |
Sun Strategies | New York, New York, United States |
Tamarind Hill | Ann Arbor, Michigan, United States |
Votorantim Novos Negocios | Brazil, São Paulo, Sao Paulo |
Wilshire Lane Partners | - |
Zhiwei Touzi | China, Jinhua Shi, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ADEL | $14M | 31 Jul 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Humanscape | $17M | 12 May 2023 | South Korea, Gyeonggi-do, South Korea | ||
SanaHeal | 01 Apr 2022 | Cambridge, Massachusetts, United States | |||
Activ Surgical | $15M | 22 Mar 2022 | Boston, Massachusetts, United States | ||
BeauBrain Healthcare | 17 Feb 2022 | - | |||
Seawith | $870K | 15 Feb 2022 | Daegu, Taegu-jikhalsi, South Korea | ||
Organoid Sciences | $17M | 13 Jan 2022 | Seongnam, Kyonggi-do, South Korea | ||
Sonic Incytes | $7M | 07 Dec 2021 | Vancouver, British Columbia, Canada | ||
GenoTwin | 01 Dec 2021 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ADEL | $14M | 31 Jul 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Humanscape | $17M | 12 May 2023 | South Korea, Gyeonggi-do, South Korea | ||
SanaHeal | 01 Apr 2022 | Cambridge, Massachusetts, United States | |||
Activ Surgical | $15M | 22 Mar 2022 | Boston, Massachusetts, United States | ||
BeauBrain Healthcare | 17 Feb 2022 | - | |||
Seawith | $870K | 15 Feb 2022 | Daegu, Taegu-jikhalsi, South Korea | ||
Organoid Sciences | $17M | 13 Jan 2022 | Seongnam, Kyonggi-do, South Korea | ||
Sonic Incytes | $7M | 07 Dec 2021 | Vancouver, British Columbia, Canada | ||
GenoTwin | 01 Dec 2021 | New York, New York, United States |